Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02141282
Title A Phase 2 Open-Label Study of the Efficacy and Safety of ABT-199 (GDC-0199) in Chronic Lymphocytic Leukemia (CLL) Subjects With Relapse or Refractory to B-Cell Receptor Signaling Pathway Inhibitor Therapy
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors AbbVie
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Moores Cancer Center at UC San Diego /ID# 128535 La Jolla California 92093 United States Details
University of California, Los Angeles /ID# 127262 Los Angeles California 90095 United States Details
Stanford University School of Med /ID# 126495 Stanford California 94305-2200 United States Details
Georgetown University Hospital /ID# 127261 Washington District of Columbia 20007 United States Details
Emory Midtown Infectious Disease Clinic /ID# 131249 Atlanta Georgia 30322 United States Details
Northwestern University Feinberg School of Medicine /ID# 126497 Chicago Illinois 60611-2927 United States Details
Beth Israel Deaconess Medical Center /ID# 134509 Boston Massachusetts 02215-5400 United States Details
Dana-Farber Cancer Institute /ID# 126496 Boston Massachusetts 02215 United States Details
Columbia Univ Medical Center /ID# 128536 New York New York 10032-3725 United States Details
New York Presbyterian Hospital Weill Cornell Medical Center /ID# 129648 New York New York 10032-3725 United States Details
Univ Rochester Med Ctr /ID# 130011 Rochester New York 14642 United States Details
The Ohio State University /ID# 127263 Columbus Ohio 43210 United States Details
University of Pennsylvania /ID# 126860 Philadelphia Pennsylvania 19104-5502 United States Details
University of Texas MD Anderson Cancer Center /ID# 126498 Houston Texas 77030 United States Details
University of Utah /ID# 130813 Salt Lake City Utah 84112-5500 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field